Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PETR SLIVA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1720654312
CMS profile
11640562
Location
INDIANAPOLIS, IN

General Payments · PY2024

$337.99

  • Reported across 19 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$337.99

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $337.99 19

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $337.99 19

Payment records · PY2024 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $25.34 10/21/2024 Food and Beverage Undisputed 01/23/2026 1116133284 CMS
Amgen Inc. $17.52 11/13/2024 Food and Beverage Undisputed 01/23/2026 1116133277 CMS
AstraZeneca Pharmaceuticals LP $18.43 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104653749 CMS
AstraZeneca Pharmaceuticals LP $14.88 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105354418 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.49 10/09/2024 Food and Beverage Undisputed 01/23/2026 1086181641 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.81 12/16/2024 Food and Beverage Undisputed 01/23/2026 1086133456 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.97 10/30/2024 Food and Beverage Undisputed 01/23/2026 1118129195 CMS
Cranial Technologies, Inc $16.93 12/19/2024 Food and Beverage Undisputed 01/23/2026 1082232854 CMS
Dynavax Technologies Corporation $13.06 10/02/2024 Food and Beverage Undisputed 01/23/2026 1082152103 CMS
Exact Sciences Corporation $14.77 11/12/2024 Food and Beverage Undisputed 01/23/2026 1114904192 CMS
Exact Sciences Corporation $17.09 12/04/2024 Food and Beverage Undisputed 01/23/2026 1114904212 CMS
Exact Sciences Corporation $17.77 12/18/2024 Food and Beverage Undisputed 01/23/2026 1114904201 CMS
Lilly USA, LLC $21.81 09/11/2024 Food and Beverage Undisputed 01/23/2026 1135324002 CMS
Novo Nordisk Inc $21.04 10/14/2024 Food and Beverage Undisputed 01/23/2026 1096597132 CMS
Novo Nordisk Inc $17.58 12/03/2024 Food and Beverage Undisputed 01/23/2026 1096924752 CMS
PFIZER INC. $16.40 09/03/2024 Food and Beverage Undisputed 01/23/2026 1131521249 CMS
PFIZER INC. $13.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 1131547060 CMS
PFIZER INC. $18.71 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131511723 CMS
Tempus AI, Inc $20.09 11/18/2024 Food and Beverage Undisputed 01/23/2026 1150174790 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.